Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1958 1
1961 4
1962 3
1963 3
1964 6
1965 3
1966 10
1967 5
1968 3
1969 3
1970 6
1971 4
1972 7
1973 11
1974 5
1975 8
1976 6
1977 10
1978 11
1979 4
1980 10
1981 10
1982 15
1983 17
1984 22
1985 15
1986 17
1987 26
1988 35
1989 38
1990 30
1991 50
1992 37
1993 43
1994 48
1995 44
1996 47
1997 49
1998 64
1999 61
2000 65
2001 52
2002 66
2003 60
2004 65
2005 78
2006 82
2007 78
2008 68
2009 100
2010 91
2011 116
2012 113
2013 120
2014 135
2015 97
2016 108
2017 115
2018 115
2019 151
2020 176
2021 187
2022 199
2023 156
2024 158
2025 146

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,364 results

Results by year

Filters applied: . Clear all
Page 1
Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.
Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, Nagatake T, Konishi K, Ohno H, Tanisawa K, Mohsen A, Chen YA, Kawashima H, Natsume-Kitatani Y, Oka Y, Shimizu H, Furuta M, Tojima Y, Sawane K, Saika A, Kondo S, Yonejima Y, Takeyama H, Matsutani A, Mizuguchi K, Miyachi M, Kunisawa J. Hosomi K, et al. Among authors: murakami h. Nat Commun. 2022 Aug 18;13(1):4477. doi: 10.1038/s41467-022-32015-7. Nat Commun. 2022. PMID: 35982037 Free PMC article.
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Smit EF, Felip E, Uprety D, Nagasaka M, Nakagawa K, Paz-Ares Rodríguez L, Pacheco JM, Li BT, Planchard D, Baik C, Goto Y, Murakami H, Saltos A, Pereira K, Taguchi A, Cheng Y, Yan Q, Feng W, Tsuchihashi Z, Jänne PA. Smit EF, et al. Among authors: murakami h. Lancet Oncol. 2024 Apr;25(4):439-454. doi: 10.1016/S1470-2045(24)00064-0. Lancet Oncol. 2024. PMID: 38547891 Clinical Trial.
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC.
Yu HA, Baik C, Kim DW, Johnson ML, Hayashi H, Nishio M, Yang JC, Su WC, Gold KA, Koczywas M, Smit EF, Steuer CE, Felip E, Murakami H, Kim SW, Su X, Sato S, Fan PD, Fujimura M, Tanaka Y, Patel P, Sternberg DW, Sellami D, Jänne PA. Yu HA, et al. Among authors: murakami h. Ann Oncol. 2024 May;35(5):437-447. doi: 10.1016/j.annonc.2024.02.003. Epub 2024 Feb 17. Ann Oncol. 2024. PMID: 38369013 Free article. Clinical Trial.
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy.
Steuer CE, Hayashi H, Su WC, Nishio M, Johnson ML, Kim DW, Massarelli E, Felip E, Gold KA, Murakami H, Baik CS, Kim SW, Smit EF, Fujimura M, Fan PD, Truchon K, Su X, Sternberg DW, Jänne PA. Steuer CE, et al. Among authors: murakami h. J Clin Oncol. 2025 Sep;43(25):2816-2826. doi: 10.1200/JCO-24-02744. Epub 2025 Jun 24. J Clin Oncol. 2025. PMID: 40554742 Free PMC article.
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.
Morgensztern D, Ready N, Johnson ML, Dowlati A, Choudhury N, Carbone DP, Schaefer E, Arnold SM, Puri S, Piotrowska Z, Hegde A, Chiang AC, Iams W, Tolcher A, Nosaki K, Kozuki T, Li T, Santana-Davila R, Akamatsu H, Murakami H, Yokouchi H, Wang S, Zha J, Li R, Robinson RR, Hingorani P, Jeng EE, Furqan M. Morgensztern D, et al. Among authors: murakami h. Clin Cancer Res. 2024 Nov 15;30(22):5042-5052. doi: 10.1158/1078-0432.CCR-24-1547. Clin Cancer Res. 2024. PMID: 39287821 Free PMC article. Clinical Trial.
CAR-NK cells derived from cord blood originate mainly from CD56-CD7+CD34-HLA-DR-Lin- NK progenitor cells.
Wibowo T, Kogue Y, Ikeda S, Yaga M, Tachikawa M, Suga M, Kida S, Shibata K, Tsutsumi K, Murakami H, Ueda Y, Kato H, Fukushima K, Fujita J, Ueda T, Kusakabe S, Hino A, Ichii M, Imai C, Okuzaki D, Kumanogoh A, Hosen N. Wibowo T, et al. Among authors: murakami h. Mol Ther Methods Clin Dev. 2024 Nov 12;32(4):101374. doi: 10.1016/j.omtm.2024.101374. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39659759 Free PMC article.
2024 Global Symposium on Health Systems Research.
Aiga H, Takizawa I, Topp SM, Murakami H, Barber SL, Kamiya Y, Rasanathan K, Hyder AA. Aiga H, et al. Among authors: murakami h. Bull World Health Organ. 2024 Mar 1;102(3):151-151A. doi: 10.2471/BLT.24.291344. Bull World Health Organ. 2024. PMID: 38434184 Free PMC article. No abstract available.
3,364 results